The FDA’s Next Decade Will Reshape Device Regulatory Hiring

CDRH Signals a Decade-Long Regulatory Science Agenda

On 25 September, the FDA's Center for Devices and Radiological Health convenes a public meeting titled Regulatory Science Innovations Catalyzing Medical Device Development, co-sponsored with the Medical Device Innovation Consortium. It caps a summer in which the agency has steadily raised the profile of regulatory science, and the framing is worth noting. 

The stated aim is to identify the regulatory science challenges likely to shape device development over the next decade, with structured discussion across three areas: AI and digital health, emerging device technologies, and evidence generation and advanced testing methods. For an industry still working through guidance on AI-enabled devices, combination products and updated quality management requirements, a meeting pitched at the next ten years rather than the current filing cycle deserves attention.

The Emphasis Is Moving Upstream, Towards Pre-Submission

Regulatory judgement is moving further upstream, becoming part of product development rather than something applied primarily at submission. That changes the regulatory hiring brief.

First, regulatory affairs is becoming more embedded in product development. Candidates need to be comfortable working alongside R&D, clinical and engineering teams before a product reaches the submission stage.

Second, pre-submission experience becomes increasingly valuable. Professionals who can anticipate regulatory questions, shape evidence strategies and engage with the FDA early can influence development decisions rather than simply respond to them.

Third, regulatory professionals need broader technical fluency. As AI, emerging devices and novel testing methods become more prominent, the strongest candidates will increasingly be those who understand not just regulation, but the technology they're regulating.

What Our Desk Can and Cannot Verify

We won't put a figure on how much faster these roles are moving, because we don't yet have verified data that would support one. What we can say from the desk is that this is a trend worth building into device regulatory hiring plans for 2027, and one we'll be following closely through the meeting on the 25th.

From the Medical Device Desk

To understand how this broader shift is translating into real hiring decisions, we asked Virginia Newman, a specialist within Neurology Solutions in our Medical Device team, what she is currently seeing across the talent market. The regulatory shift is part of a broader change we're seeing across Medical Device hiring: employers increasingly want people who can bridge technical, clinical and commercial complexity.

From the commercial side of Neurology Medical Device, I’m seeing more companies looking for candidates who have strong commercial experience but also really understand the clinical side of neuro and the technology they’re selling. Especially with newer and more disruptive technologies like BCIs, neuromodulation and emerging neurodiagnostics, clients want people who can educate physicians, drive adoption and help build out a market, rather than just manage an existing territory.

Planning Device Regulatory Hiring into 2027?

Planning your 2027 regulatory hiring strategy? Our Medical Device team can help you benchmark your regulatory capability against where the FDA is heading and identify the specialist talent you'll need next.